Radionuclide synovectomy in haemophilic joints

Nucl Med Commun. 2013 Apr;34(4):291-7. doi: 10.1097/MNM.0b013e32835ed50c.

Abstract

Chronic synovitis often occurs in people with haemophilia. Untreated chronic haemophilic synovitis affects the metabolism of chondrocytes, thus leading to haemophilic arthropathy. A recently introduced therapeutic protocol includes radiation synovectomy (RS), a safe and cost-effective therapeutic method, which has given satisfactory results in 75% of haemophiliacs with chronic hypertrophic synovitis. Because of its efficacy, we will discuss additional recommendations on the use of RS as a method of choice. The focus of this review is haemophilic arthropathy treatment, including its aetiopathogenesis, reasons for RS indication and its mechanism of action, and use of radioisotopes and other agents for treatment.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Age Factors
  • Hemophilia A / surgery*
  • Humans
  • Radiopharmaceuticals / therapeutic use
  • Radiosurgery / adverse effects
  • Radiosurgery / methods*
  • Safety
  • Synovectomy*

Substances

  • Radiopharmaceuticals